Novel Approaches to the Study of Neonatal Infections

Alessandro Borghesi, Mauro Stronati, Riccardo Castagnoli, Irene Ioimo, Cristian Achille, Paolo Manzoni, Chryssoula Tzialla

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The pathogenesis of neonatal infection is incompletely understood. Neonatal immune immaturity and the microbial factors of virulence only partially explain the interindividual differences in the protective responses to the most common neonatal pathogens. Stratification of infants into high- and low-risk groups through epidemiological studies has been invaluable in designing preventive strategies and reducing the burden of neonatal infection. The discovery of the role of maternal antibodies (Abs) as, for instance, anti-capsular polysaccharide group B streptococcal (GBS) Abs, in protecting newborn infants against neonatal GBS sepsis, has been a milestone in the unraveling of the molecular underpinnings of susceptibility to infection in the neonatal age. Future work should aim at defining the cellular and molecular differences in the neonatal immune responses that account for individual susceptibility and resistance to common neonatal pathogens. The interplay between the genetic and immune backgrounds of the infant, changes in the infant's microbiome, maternal factors, and the pathogen's characteristics needs to be accurately described through human studies. Precise phenotyping and dissection of the clinical heterogeneity of neonatal infection should identify cohorts that can be studied through different study methodologies. Term and preterm infants should be investigated according to the most likely underlying mechanism, single-gene disorders and multifactorial predisposition, respectively. Novel technologies, including genotyping studies, exome and genome sequencing, analysis of the microbiome, and the study of the metabolome, are nowadays established and available and can be integrated to gain a better insight into the unexplained bases of individual susceptibility to neonatal infections.

Original languageEnglish
Pages (from-to)570-574
Number of pages5
JournalAmerican Journal of Perinatology
Volume35
Issue number6
DOIs
Publication statusPublished - May 1 2018
Externally publishedYes

Fingerprint

Infection
Microbiota
Mothers
Exome
Metabolome
Antibodies
Virulence Factors
Premature Infants
Polysaccharides
Dissection
Epidemiologic Studies
Sepsis
Newborn Infant
Genome
Technology
Genes
Genetic Background

Keywords

  • genetic
  • infection
  • newborn infant
  • phenotype
  • primary immunodeficiency
  • single-gene

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

Novel Approaches to the Study of Neonatal Infections. / Borghesi, Alessandro; Stronati, Mauro; Castagnoli, Riccardo; Ioimo, Irene; Achille, Cristian; Manzoni, Paolo; Tzialla, Chryssoula.

In: American Journal of Perinatology, Vol. 35, No. 6, 01.05.2018, p. 570-574.

Research output: Contribution to journalArticle

Borghesi, Alessandro ; Stronati, Mauro ; Castagnoli, Riccardo ; Ioimo, Irene ; Achille, Cristian ; Manzoni, Paolo ; Tzialla, Chryssoula. / Novel Approaches to the Study of Neonatal Infections. In: American Journal of Perinatology. 2018 ; Vol. 35, No. 6. pp. 570-574.
@article{903cb36a588d4e88b3084d834a1d70da,
title = "Novel Approaches to the Study of Neonatal Infections",
abstract = "The pathogenesis of neonatal infection is incompletely understood. Neonatal immune immaturity and the microbial factors of virulence only partially explain the interindividual differences in the protective responses to the most common neonatal pathogens. Stratification of infants into high- and low-risk groups through epidemiological studies has been invaluable in designing preventive strategies and reducing the burden of neonatal infection. The discovery of the role of maternal antibodies (Abs) as, for instance, anti-capsular polysaccharide group B streptococcal (GBS) Abs, in protecting newborn infants against neonatal GBS sepsis, has been a milestone in the unraveling of the molecular underpinnings of susceptibility to infection in the neonatal age. Future work should aim at defining the cellular and molecular differences in the neonatal immune responses that account for individual susceptibility and resistance to common neonatal pathogens. The interplay between the genetic and immune backgrounds of the infant, changes in the infant's microbiome, maternal factors, and the pathogen's characteristics needs to be accurately described through human studies. Precise phenotyping and dissection of the clinical heterogeneity of neonatal infection should identify cohorts that can be studied through different study methodologies. Term and preterm infants should be investigated according to the most likely underlying mechanism, single-gene disorders and multifactorial predisposition, respectively. Novel technologies, including genotyping studies, exome and genome sequencing, analysis of the microbiome, and the study of the metabolome, are nowadays established and available and can be integrated to gain a better insight into the unexplained bases of individual susceptibility to neonatal infections.",
keywords = "genetic, infection, newborn infant, phenotype, primary immunodeficiency, single-gene",
author = "Alessandro Borghesi and Mauro Stronati and Riccardo Castagnoli and Irene Ioimo and Cristian Achille and Paolo Manzoni and Chryssoula Tzialla",
year = "2018",
month = "5",
day = "1",
doi = "10.1055/s-0038-1639360",
language = "English",
volume = "35",
pages = "570--574",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers, Inc.",
number = "6",

}

TY - JOUR

T1 - Novel Approaches to the Study of Neonatal Infections

AU - Borghesi, Alessandro

AU - Stronati, Mauro

AU - Castagnoli, Riccardo

AU - Ioimo, Irene

AU - Achille, Cristian

AU - Manzoni, Paolo

AU - Tzialla, Chryssoula

PY - 2018/5/1

Y1 - 2018/5/1

N2 - The pathogenesis of neonatal infection is incompletely understood. Neonatal immune immaturity and the microbial factors of virulence only partially explain the interindividual differences in the protective responses to the most common neonatal pathogens. Stratification of infants into high- and low-risk groups through epidemiological studies has been invaluable in designing preventive strategies and reducing the burden of neonatal infection. The discovery of the role of maternal antibodies (Abs) as, for instance, anti-capsular polysaccharide group B streptococcal (GBS) Abs, in protecting newborn infants against neonatal GBS sepsis, has been a milestone in the unraveling of the molecular underpinnings of susceptibility to infection in the neonatal age. Future work should aim at defining the cellular and molecular differences in the neonatal immune responses that account for individual susceptibility and resistance to common neonatal pathogens. The interplay between the genetic and immune backgrounds of the infant, changes in the infant's microbiome, maternal factors, and the pathogen's characteristics needs to be accurately described through human studies. Precise phenotyping and dissection of the clinical heterogeneity of neonatal infection should identify cohorts that can be studied through different study methodologies. Term and preterm infants should be investigated according to the most likely underlying mechanism, single-gene disorders and multifactorial predisposition, respectively. Novel technologies, including genotyping studies, exome and genome sequencing, analysis of the microbiome, and the study of the metabolome, are nowadays established and available and can be integrated to gain a better insight into the unexplained bases of individual susceptibility to neonatal infections.

AB - The pathogenesis of neonatal infection is incompletely understood. Neonatal immune immaturity and the microbial factors of virulence only partially explain the interindividual differences in the protective responses to the most common neonatal pathogens. Stratification of infants into high- and low-risk groups through epidemiological studies has been invaluable in designing preventive strategies and reducing the burden of neonatal infection. The discovery of the role of maternal antibodies (Abs) as, for instance, anti-capsular polysaccharide group B streptococcal (GBS) Abs, in protecting newborn infants against neonatal GBS sepsis, has been a milestone in the unraveling of the molecular underpinnings of susceptibility to infection in the neonatal age. Future work should aim at defining the cellular and molecular differences in the neonatal immune responses that account for individual susceptibility and resistance to common neonatal pathogens. The interplay between the genetic and immune backgrounds of the infant, changes in the infant's microbiome, maternal factors, and the pathogen's characteristics needs to be accurately described through human studies. Precise phenotyping and dissection of the clinical heterogeneity of neonatal infection should identify cohorts that can be studied through different study methodologies. Term and preterm infants should be investigated according to the most likely underlying mechanism, single-gene disorders and multifactorial predisposition, respectively. Novel technologies, including genotyping studies, exome and genome sequencing, analysis of the microbiome, and the study of the metabolome, are nowadays established and available and can be integrated to gain a better insight into the unexplained bases of individual susceptibility to neonatal infections.

KW - genetic

KW - infection

KW - newborn infant

KW - phenotype

KW - primary immunodeficiency

KW - single-gene

UR - http://www.scopus.com/inward/record.url?scp=85045890959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045890959&partnerID=8YFLogxK

U2 - 10.1055/s-0038-1639360

DO - 10.1055/s-0038-1639360

M3 - Article

VL - 35

SP - 570

EP - 574

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 6

ER -